The Journal of Rheumatology

First published in 1974, The Journal of Rheumatology is a monthly international serial edited by Earl D. Silverman. The Journal features peer-reviewed research articles on clinical subjects from scientists working in rheumatology and related fields, with the support of our esteemed Editorial Committee and Editorial Board.

According to The Canadian Essential Journal Study, The Journal of Rheumatology is ranked among the top 3 essential publications for rheumatology. In fact, 74% of rheumatologists consider The Journal of Rheumatology an essential journal, making it the top journal in the specialty.

The Journal of Rheumatology publishes timely clinical research papers every month, both in print and online. With thousands of citations per year, The Journal of Rheumatology’s influence and reach extends to over 3600 subscribers globally and to all active members of the Canadian Rheumatology Association, including rheumatology residents and trainees. Since it was established over 50 years ago, The Journal of Rheumatology’s content remains highly relevant to rheumatologists because of the emphasis on continuity while embracing innovation.

With over 1600 submissions a year from over 50 countries, each issue of The Journal of Rheumatology includes original clinical research articles, metaanalyses, systematic reviews, editorials, historical vignettes, case reports, and letters by world-renowned experts studying drug therapy, patient-reported outcomes, discovery of therapeutic targets in the treatment of rheumatic diseases such as rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, osteoarthritis, and other rheumatic and musculoskeletal diseases.

The Journal of Rheumatology features proceedings of national and international conferences or symposia presented by renowned rheumatologists from Canada and abroad in The Journal of Rheumatology Supplements. These timely supplements typically highlight reports on the mechanisms of rheumatic diseases and updates on emerging therapies.

Clinical Highlights for the Rheumatologist

Beginning in 2012, a bimonthly print edition was launched in the USA and distributed to 4200 rheumatologists, called Clinical Highlights for the Rheumatologist (CHR). Articles that appear in CHR have been selected from the most recent issues of The Journal of Rheumatology by the Editor-in-Chief for their high interest to the clinical rheumatologist.

Duncan A. Gordon Award

Honoring longtime editor of The Journal of Rheumatology, the annual Duncan A. Gordon Award acknowledges highly influential research articles published in The Journal based on their impact and originality, and their potential to advance treatment and alter clinical practice.

Editorial Office

365 Bloor Street East
Suite 901
Toronto, ON
M4W 3L4
Canada
Tel.: (416) 967-5155
Fax: (416) 967-7556
Email: jrheum@jrheum.com

The Journal of Rheumatology is owned by the Canadian Rheumatology Association Foundation, a charity dedicated to supporting research, education, and care delivery by rheumatology professionals for people with rheumatic diseases. . This journal is published monthly by The Journal of Rheumatology Publishing Co. Ltd.

While the owner, publisher, and authors try to ensure that all materials in The Journal of Rheumatology are accurate, complete, and current, they make no guarantees or warranties as to such currency, completeness, or accuracy of the results to be obtained from accessing and using the materials. The publisher and owner do not endorse any information, advice, or other material. The owner, publisher, and authors expressly disclaim all representations, warranties of merchantability, or fitness for a particular purpose. They accept no responsibility or liability for damages or losses relating to any errors in or omissions from any material or from the use or inability to use such material.